文献速递血栓与止血

住院COVID-19患者静脉血栓栓塞症的发生率

Incidence of venous thromboembolism in hospitalized patients with COVID-19.
PubMed 文献 · J Thromb Haemost · 2020-07-27

这项单中心队列研究纳入198例住院COVID-19患者,中位随访7天期间20%确诊静脉血栓栓塞症(VTE),其中13%为症状性VTE;ICU患者VTE累积发生率高于普通病房;VTE似乎与死亡相关(校正HR 2.4,95%CI 1.02-5.5)。

要点

  • 住院COVID-19患者中位随访7天VTE发生率为20%,症状性VTE为13%。
  • ICU患者7、14、21天VTE累积发生率分别为26%、47%、59%,高于普通病房。
  • VTE似乎与死亡相关,校正HR 2.4(95%CI 1.02-5.5)。

核心结论

  • COVID-19患者观察到的VTE风险较高,尤其是ICU患者,应保持高度临床怀疑并对深静脉血栓或肺栓塞采用低门槛诊断影像检查。
  • 未来研究应聚焦于预防VTE并可能改善生存的最佳诊断和预防策略。

研究设计与样本

  • 单中心队列研究,纳入198例住院COVID-19患者。

主要发现

  • 75例(38%)入住ICU;数据收集时16例(8%)仍在住院,19%已死亡。
  • 中位随访7天(IQR 3-13)期间,39例(20%)诊断为VTE,其中25例(13%)为症状性VTE,尽管进行了常规血栓预防。
  • VTE在7、14、21天的累积发生率分别为16%(95%CI 10-22)、33%(95%CI 23-43)、42%(95%CI 30-54)。
  • 症状性VTE在7、14、21天的累积发生率分别为10%(95%CI 5.8-16)、21%(95%CI 14-30)、25%(95%CI 16-36)。
  • VTE似乎与死亡相关(校正HR 2.4;95%CI 1.02-5.5)。

关键数值与推荐

  • ICU患者VTE累积发生率在7、14、21天分别为26%(95%CI 17-37)、47%(95%CI 34-58)、59%(95%CI 42-72)。
  • 普通病房任何VTE和症状性VTE在7、14、21天的累积发生率均为5.8%(95%CI 1.4-15)、9.2%(95%CI 2.6-21)、9.2%(2.6-21)。

临床怎么用

  • 作者认为,COVID-19患者VTE风险较高,尤其是ICU患者,应对深静脉血栓或肺栓塞保持高度临床怀疑并对诊断影像检查采用低门槛。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Coronavirus disease 2019 (COVID-19) can lead to systemic coagulation activation and thrombotic complications. OBJECTIVES: To investigate the incidence of objectively confirmed venous thromboembolism (VTE) in hospitalized patients with COVID-19. METHODS: Single-center cohort study of 198 hospitalized patients with COVID-19. RESULTS: Seventy-five patients (38%) were admitted to the intensive care unit (ICU). At time of data collection, 16 (8%) were still hospitalized and 19% had died. During a median follow-up of 7 days (IQR, 3-13), 39 patients (20%) were diagnosed with VTE of whom 25 (13%) had symptomatic VTE, despite routine thrombosis prophylaxis. The cumulative incidences of VTE at 7, 14 and 21 days were 16% (95% CI, 10-22), 33% (95% CI, 23-43) and 42% (95% CI 30-54) respectively. For symptomatic VTE, these were 10% (95% CI, 5.8-16), 21% (95% CI, 14-30) and 25% (95% CI 16-36). VTE appeared to be associated with death (adjusted HR, 2.4; 95% CI, 1.02-5.5). The cumulative incidence of VTE was higher in the ICU (26% (95% CI, 17-37), 47% (95% CI, 34-58), and 59% (95% CI, 42-72) at 7, 14 and 21 days) than on the wards (any VTE and symptomatic VTE 5.8% (95% CI, 1.4-15), 9.2% (95% CI, 2.6-21), and 9.2% (2.6-21) at 7, 14, and 21 days). CONCLUSIONS: The observed risk for VTE in COVID-19 is high, particularly in ICU patients, which should lead to a high level of clinical suspicion and low threshold for diagnostic imaging for DVT or PE. Future research should focus on optimal diagnostic and prophylactic strategies to prevent VTE and potentially improve survival.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020. PMID: 32369666. doi:10.1111/jth.14888

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。